TLR7/8 agonist 4 hydroxy-PEG6-acid (hydrochloride)

• UNSPSC Description:

  TLR7/8 agonist 4 hydroxy-PEG6-acid hydrochloride is a Drug-Linker Conjugates for ADC. TLR7/8 agonist 4 hydroxy-PEG6-acid hydrochloride is the hydrochloride form of TLR7/8 agonist 4 hydroxy-PEG6-acid. TLR7/8 agonist 4 hydroxy-PEG6-acid consists of TLR7/8 agonist 4 (HY-139017) and a linker Hydroxy-PEG6-acid (HY-133050), and can be used for synthesis of ADCs[1].

• Target Antigen:

  Drug-Linker Conjugates for ADC

• Type:

  Reference compound

• Related Pathways:

  Antibody-drug Conjugate/ADC Related

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/tlr7-8-agonist-4-hydroxy-peg6-acid-hydrochloride.html

• Solubility:

  DMSO : < 1 mg/mL (ultrasonic;warming;heat to 60°C)|H2O : 50 mg/mL (ultrasonic)

• Smiles:

  O=C(CCOCCOCCOCCOCCOCCOCCN1CCN(CC1)C2=CC3=C(N=C(C4=C3NC(CCCC)=N4)N)C=C2)O.Cl

• Molecular Weight:

  697.26

• References & Citations:

  [1]Shelley Erin ACKERMAN, et al. Macromolecule-supported tlr agonists. Patent. WO2020190762A1.

• Shipping Conditions:

  Blue Ice

• Clinical Information:

  No Development Reported